EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test
At DNA Labs UAE, we offer the EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test for individuals who may be at risk for this condition. This test can provide important information for diagnosis, genetic counseling, family planning, and potential treatment options.
Test Components
The EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test includes:
- NGS Technology
- Neurological Disorders
- Genetics
Price
The cost of the EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test is 4400.0 AED.
Sample Condition
We accept the following sample conditions for this test:
- Blood
- Extracted DNA
- One drop Blood on FTA Card
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Method
The EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test is performed using NGS (Next-Generation Sequencing) technology.
Test Type
This test is specifically designed for the diagnosis of neurological disorders, including myoclonic epilepsy of Lafora (MEOL).
Doctor
This test is recommended by a neurologist.
Test Department
The EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the EPM2A Gene Myoclonic epilepsy of Lafora NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by MEOL.
Test Details
The EPM2A gene is associated with myoclonic epilepsy of Lafora (MEOL), a rare and progressive form of epilepsy characterized by seizures, myoclonus (sudden muscle jerks), and cognitive decline. MEOL is caused by the accumulation of abnormal proteins known as Lafora bodies in the brain.
NGS genetic testing, such as the EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test, allows for the simultaneous analysis of multiple genes associated with MEOL. This test can identify mutations or variants in the EPM2A gene that may be responsible for the development of the condition. It can confirm a diagnosis of MEOL, provide important information for genetic counseling, family planning, and potential treatment options. It can also be used for carrier testing in individuals with a family history of MEOL.
It is crucial to consult with a healthcare professional or genetic counselor for further information and guidance regarding NGS genetic testing for MEOL and the interpretation of test results.
Test Name | EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EPM2A Gene Myoclonic epilepsy of Lafora NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EPM2A Gene Myoclonic epilepsy of Lafora |
Test Details |
The EPM2A gene is associated with a type of epilepsy called myoclonic epilepsy of Lafora (MEOL). MEOL is a rare, progressive form of epilepsy characterized by seizures, myoclonus (sudden muscle jerks), and cognitive decline. It is caused by the accumulation of abnormal proteins called Lafora bodies in the brain. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes associated with a particular condition. In the case of MEOL, NGS genetic testing can be used to identify mutations or variants in the EPM2A gene that may be responsible for the development of the condition. NGS genetic testing can help confirm a diagnosis of MEOL and provide important information for genetic counseling, family planning, and potential treatment options. It may also be used for carrier testing in individuals with a family history of MEOL. It is important to consult with a healthcare professional or genetic counselor for further information and guidance regarding NGS genetic testing for MEOL and the interpretation of test results. |